ID

13389

Descripción

Neoadjuvant Herceptin in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00133796

Link

https://clinicaltrials.gov/show/NCT00133796

Palabras clave

  1. 10/2/16 10/2/16 -
Subido en

10 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00133796

Eligibility Breast Cancer NCT00133796

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
All patients must be female.
Descripción

gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
Informed consent must be signed.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Women with locally advanced breast cancers or primary breast cancers with concomitant gross metastatic disease are eligible. locally advanced cancers must be of clinical and/or radiologic size > 4 cm, and/or are deemed surgically inoperable.
Descripción

locally advanced breast cancers

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677984
UMLS CUI [1,2]
C0006141
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0006141
UMLS CUI [2,3]
C0205225
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C0027627
Her2/neu overexpressing tumors defined as herceptest score of 3+, or >/= one-third of invasive tumor showing membranous staining, or fluorescence in situ hybridization (fish) positive.
Descripción

Her2neu overexpressing tumors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1960398
Negative serum pregnancy test (bhcg) within 7 days of starting study, if of child-bearing potential.
Descripción

pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0430060
kidney and liver function tests - all within 1.5 times of the institution's upper limit of normal.
Descripción

kidney and liver function tests

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232805
UMLS CUI [2]
C0232741
Performance status (world health organization [who] scale) < 2 and life expectancy > 6 months.
Descripción

performance status and life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0023671
Age > 18.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
No metastatic disease without concomitant primary breast cancer.
Descripción

primary breast cancer and metastatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0006141
UMLS CUI [1,3]
C0205225
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0027627
No previous or current malignancies at other sites within the last 5 years, with exception of adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
Descripción

other malignancies

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
Pregnancy or unwillingness to use a reliable contraceptive method in women of child-bearing potential.
Descripción

pregnancy and contraceptive use

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C1999124
Severe underlying chronic illness or disease.
Descripción

severe comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
Cardiomyopathy or baseline left ventricular ejection fraction (lvef) < 50%.
Descripción

cardiomyopathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0878544
UMLS CUI [2]
C0428772
Patients on other investigational drugs while on study.
Descripción

participation in another trial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
Severe or uncontrolled hypertension defined as blood pressure (bp) > 180/100 on three separate occasions.
Descripción

hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C1868885
UMLS CUI [3]
C0005823
History of congestive heart failure.
Descripción

history of CHF

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018802
History of coronary arterial disease.
Descripción

history of CAD

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1956346

Similar models

Eligibility Breast Cancer NCT00133796

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
gender
Item
All patients must be female.
boolean
C0079399 (UMLS CUI [1])
informed consent
Item
Informed consent must be signed.
boolean
C0021430 (UMLS CUI [1])
locally advanced breast cancers
Item
Women with locally advanced breast cancers or primary breast cancers with concomitant gross metastatic disease are eligible. locally advanced cancers must be of clinical and/or radiologic size > 4 cm, and/or are deemed surgically inoperable.
boolean
C0677984 (UMLS CUI [1,1])
C0006141 (UMLS CUI [1,2])
C0006826 (UMLS CUI [2,1])
C0006141 (UMLS CUI [2,2])
C0205225 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
Her2neu overexpressing tumors
Item
Her2/neu overexpressing tumors defined as herceptest score of 3+, or >/= one-third of invasive tumor showing membranous staining, or fluorescence in situ hybridization (fish) positive.
boolean
C1960398 (UMLS CUI [1])
pregnancy test
Item
Negative serum pregnancy test (bhcg) within 7 days of starting study, if of child-bearing potential.
boolean
C0430060 (UMLS CUI [1])
kidney and liver function tests
Item
kidney and liver function tests - all within 1.5 times of the institution's upper limit of normal.
boolean
C0232805 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
performance status and life expectancy
Item
Performance status (world health organization [who] scale) < 2 and life expectancy > 6 months.
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
age
Item
Age > 18.
boolean
C0001779 (UMLS CUI [1])
primary breast cancer and metastatic disease
Item
No metastatic disease without concomitant primary breast cancer.
boolean
C0006826 (UMLS CUI [1,1])
C0006141 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
C0009488 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
other malignancies
Item
No previous or current malignancies at other sites within the last 5 years, with exception of adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy and contraceptive use
Item
Pregnancy or unwillingness to use a reliable contraceptive method in women of child-bearing potential.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C1999124 (UMLS CUI [3])
severe comorbidity
Item
Severe underlying chronic illness or disease.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
cardiomyopathy
Item
Cardiomyopathy or baseline left ventricular ejection fraction (lvef) < 50%.
boolean
C0878544 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
participation in another trial
Item
Patients on other investigational drugs while on study.
boolean
C2348568 (UMLS CUI [1])
hypertension
Item
Severe or uncontrolled hypertension defined as blood pressure (bp) > 180/100 on three separate occasions.
boolean
C0020538 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2])
C0005823 (UMLS CUI [3])
history of CHF
Item
History of congestive heart failure.
boolean
C0018802 (UMLS CUI [1])
history of CAD
Item
History of coronary arterial disease.
boolean
C1956346 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial